These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25348612)

  • 1. Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
    Feng Y; Sassi S; Shen JK; Yang X; Gao Y; Osaka E; Zhang J; Yang S; Yang C; Mankin HJ; Hornicek FJ; Duan Z
    J Orthop Res; 2015 Feb; 33(2):199-207. PubMed ID: 25348612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
    Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
    Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma.
    Liang C; Li F; Wang L; Zhang ZK; Wang C; He B; Li J; Chen Z; Shaikh AB; Liu J; Wu X; Peng S; Dang L; Guo B; He X; Au DWT; Lu C; Zhu H; Zhang BT; Lu A; Zhang G
    Biomaterials; 2017 Dec; 147():68-85. PubMed ID: 28938163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library.
    Wu Y; Zhou L; Wang Z; Wang X; Zhang R; Zheng L; Kang T
    Cancer Biol Med; 2020 Aug; 17(3):782-794. PubMed ID: 32944406
    [No Abstract]   [Full Text] [Related]  

  • 5. Transcriptional activation of CBFβ by CDK11
    Feng Y; Liao Y; Zhang J; Shen J; Shao Z; Hornicek F; Duan Z
    Cell Commun Signal; 2019 Oct; 17(1):125. PubMed ID: 31610798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation.
    Duan Z; Zhang J; Choy E; Harmon D; Liu X; Nielsen P; Mankin H; Gray NS; Hornicek FJ
    Clin Cancer Res; 2012 Sep; 18(17):4580-8. PubMed ID: 22791884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells.
    Liao Y; Chen L; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z
    Oncotarget; 2017 May; 8(18):30276-30287. PubMed ID: 28415820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.
    Liao Y; Sassi S; Halvorsen S; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z
    Sci Rep; 2017 Mar; 7():43941. PubMed ID: 28262798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and application of a human osteosarcoma U-2OS cell line that can stably express Cas9 protein.
    Zhou Y; Li Y; Zhang Y; Yi Z; Jiang M
    Mol Cell Biochem; 2022 Sep; 477(9):2183-2191. PubMed ID: 35445373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of CRISPR/Cas9 in the research of malignant musculoskeletal tumors.
    Liu W; Wang S; Lin B; Zhang W; Ji G
    BMC Musculoskelet Disord; 2021 Feb; 22(1):149. PubMed ID: 33546657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells.
    Liu T; Yan Z; Liu Y; Choy E; Hornicek FJ; Mankin H; Duan Z
    Cell Physiol Biochem; 2018; 46(3):1218-1230. PubMed ID: 29672299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer.
    Zhou Y; Shen JK; Hornicek FJ; Kan Q; Duan Z
    Oncotarget; 2016 Jun; 7(26):40846-40859. PubMed ID: 27049727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
    Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
    J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma.
    Mizoshiri N; Shirai T; Terauchi R; Tsuchida S; Mori Y; Hayashi D; Kishida T; Arai Y; Mazda O; Nakanishi T; Kubo T
    Cell Oncol (Dordr); 2019 Dec; 42(6):861-871. PubMed ID: 31494861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
    Pan W; Wang H; Jianwei R; Ye Z
    Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
    Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
    Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK11
    Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q
    Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting mutant TP53 as a potential therapeutic strategy for the treatment of osteosarcoma.
    Tang F; Min L; Seebacher NA; Li X; Zhou Y; Hornicek FJ; Wei Y; Tu C; Duan Z
    J Orthop Res; 2019 Mar; 37(3):789-798. PubMed ID: 30667081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells.
    Jafari N; Kim H; Park R; Li L; Jang M; Morris AJ; Park J; Huang C
    PLoS One; 2017; 12(1):e0170327. PubMed ID: 28099519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.